Deferred Tax Assets, Valuation Allowance of Opus Genetics, Inc. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Opus Genetics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • Opus Genetics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $39,997,000, a 13% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Opus Genetics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $39,997,000 +$4,594,000 +13% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q4 2024 $35,403,000 +$15,262,000 +76% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q4 2023 $20,141,000 +$2,371,000 +13% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $17,770,000 -$3,892,000 -18% 31 Dec 2022 10-K 08 Mar 2024 2023 FY
Q4 2021 $21,662,000 +$17,015,000 +366% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 $4,647,000 +$2,788,000 +150% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 $46,115,000 +$1,047,000 +2.3% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $45,610,000 +$1,159,000 +2.6% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $44,944,000 +$917,000 +2.1% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $1,859,000 -$41,128,000 -96% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 $45,068,000 +$3,404,000 +8.2% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $44,451,000 +$3,993,000 +9.9% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $44,027,000 +$4,877,000 +12% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $42,987,000 +$5,359,000 +14% 31 Dec 2018 10-K 21 Feb 2020 2019 FY
Q3 2018 $41,664,000 -$8,879,000 -18% 30 Sep 2018 10-Q 02 Nov 2018 2018 Q3
Q2 2018 $40,458,000 -$8,712,000 -18% 30 Jun 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 $39,150,000 -$8,379,000 -18% 31 Mar 2018 10-Q 04 May 2018 2018 Q1
Q4 2017 $37,628,000 -$8,413,000 -18% 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q3 2017 $50,543,000 +$5,116,000 +11% 30 Sep 2017 10-Q 03 Nov 2017 2017 Q3
Q2 2017 $49,170,000 +$5,187,000 +12% 30 Jun 2017 10-Q 04 Aug 2017 2017 Q2
Q1 2017 $47,529,000 +$4,786,000 +11% 31 Mar 2017 10-Q 03 May 2017 2017 Q1
Q4 2016 $46,041,000 +$5,178,000 +13% 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q3 2016 $45,427,000 +$5,570,000 +14% 30 Sep 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 $43,983,000 +$6,006,000 +16% 30 Jun 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 $42,743,000 +$6,595,000 +18% 31 Mar 2016 10-Q 06 May 2016 2016 Q1
Q4 2015 $40,863,000 +$6,395,000 +19% 31 Dec 2015 10-K 24 Feb 2017 2016 FY
Q3 2015 $39,857,000 +$6,968,000 +21% 30 Sep 2015 10-Q 02 Nov 2015 2015 Q3
Q2 2015 $37,977,000 +$6,409,100 +20% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 $36,148,000 +$5,804,500 +19% 31 Mar 2015 10-Q 08 May 2015 2015 Q1
Q4 2014 $34,468,000 +$5,091,800 +17% 31 Dec 2014 10-K 14 Mar 2016 2015 FY
Q3 2014 $32,889,000 +$4,447,600 +16% 30 Sep 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 $31,567,900 +$3,827,500 +14% 30 Jun 2014 10-Q 13 Aug 2014 2014 Q2
Q1 2014 $30,343,500 +$3,331,600 +12% 31 Mar 2014 10-Q 14 May 2014 2014 Q1
Q4 2013 $29,376,200 +$3,086,500 +12% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 $28,441,400 +$2,561,800 +9.9% 30 Sep 2013 10-Q 13 Nov 2013 2013 Q3
Q2 2013 $27,740,400 +$52,923,700 30 Jun 2013 10-Q 12 Aug 2013 2013 Q2
Q1 2013 $27,011,900 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 $26,289,700 +$2,584,000 +11% 31 Dec 2012 10-K 21 Mar 2014 2013 FY
Q3 2012 $25,879,600 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 $25,183,300 30 Jun 2012 10-Q 08 Aug 2012 2012 Q2
Q4 2011 $23,705,700 31 Dec 2011 10-K 22 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.